Novo Nordisk

NVO · United States

Novo Nordisk traded $350.9M on 23 Oct 2026, 0.8× its 20-session average. Sector: Metabolic & GLP-1 Pharma.

504 trading days of history, to 2026-10-23 · all values converted to USD

Last close
$39.05
23 Oct
1-day change
-0.96%
vs previous close
Company value, all classes
$174.4B
Turnover
0.20%
of company value traded
Dollar volume
$350.9M
as of 23 Oct
vs prior 20 sessions
0.8×
as of 23 Oct
Share of market volume
0.09%
as of 23 Oct
Volatility
47.9%
annualised

Share classes

NVO is one class of a company with several. The company is valued once: every counted class at its own price, or a class that converts at the price of the class it converts into. Counts from the company's 20-F, as of 2025-12-31 (an annual report: the count is updated once a year).

  • A shares1.07bn · counted at the listed class's close: the same dividends per share and an equal share on liquidation
    “However, in practice, A shares and B shares receive the same amount of dividends per share of DKK 0.01.” — 20-F (filed 4 Feb 2026), Exhibit 2.2, rights attaching to the shares
  • B shares3.39bn · this line, at its own close

Infinity volume insights

since 14 April 2025

Every session our rules flagged for this company since 14 April 2025: 18. Those marked “In the feed” were published in the daily feed at the time; the rest are computed with the rules in use now. The feed shows a few a day across every market, so most never appear there. We began tracking this company on 28 September 2026; findings before then are marked “Before we tracked it”: it traded that way, and we were not yet watching.

  1. 2026-09-21Before we tracked it

    Novo Nordisk moved -8.0% on 4.4× its average dollar volume

    2.5 standard deviations from its usual daily change (standard deviation 3.1% across 479 earlier sessions). $2.0B against a 20-day average of $451.0M, on a falling price (-8.0%). Dollar volume 4.4× normal; turnover 1.1% of market cap (5.0× its usual turnover).

The latest is shown; the other 17 open with the full page.

This is a preview

A free account opens five company pages a day in full: every insight, the year's chart, the volume by week and month, fundamentals and peers. Members open every company, with full charting.

See what moves Novo Nordisk's share price For members · Sign in

Prices and volume via the daily pipeline, converted to USD.

Report data issue

← Back to United States